The upcoming report from Alcoa (AA) is expected to reveal quarterly earnings of $0.30 per share, indicating an increase of 87.5% compared to the year-ago period. Analysts forecast revenues of $2.91 billion, representing an increase of 0.3% year over year.The consensus EPS estimate for the quarter has been revised 4.8% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Before a compan ...

Rogers Communication (RCI) shares rallied 5.1% in the last trading session to close at $31.86. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 13.3% gain over the past four weeks.Rogers Communication is benefiting from disciplined execution through cost efficiencies, industry-leading 5G and internet reliability, and growing value in its sports assets, all of which are helping it deliver steady growth and redu ...

Sonoco (SON) shares rallied 5% in the last trading session to close at $45.74. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 2.6% loss over the past four weeks.Sonoco’s shares gained since the company announced it will report the second quarter 2025 results on July 23. In the first quarter of 2025, Sonoco reported adjusted earnings per share of $1.38 in the first quarter of 2025. The bottom line improved 23 ...

MRC Global (MRC) shares ended the last trading session 11.8% higher at $14.89. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 6.2% gain over the past four weeks.Shares of MRC Global rallied following the news of its planned acquisition by DNOW Inc. (DNOW) . The two entities inked a merger deal per which, DNOW will buy all outstanding shares of MRC Global for approximately $1.5 billion, which includes the latter’s ...

Enova International (ENVA) shares rallied 5.2% in the last trading session to close at $111.01. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 13.1% gain over the past four weeks.Enova International widens gains for seventh straight trading session. The rally was fueled by broad market optimism surrounding potential trade agreements and growing expectations of earlier-than-anticipated interest rate cuts by t ...

Group 1 - Grupo Cibest (CIB) shares increased by 5.5% to close at $44.97, with trading volume significantly higher than usual, compared to a 2.5% gain over the past four weeks [1][2] - The rise in CIB's share price is attributed to reduced geopolitical tensions in the Middle East following President Trump's intervention, which has boosted investor confidence in global stock markets [2] - CIB is expected to report quarterly earnings of $1.63 per share, reflecting a year-over-year increase of 13.2%, with revenues projected at $1.83 billion, up 3% from the previous year [3] Group 2 - The consensus EPS estimate for CIB has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] - CIB currently holds a Zacks Rank of 3 (Hold), indicating a neutral outlook [5] - KBC Group, a peer in the same industry, has a consensus EPS estimate of $1.34, representing a year-over-year change of 10.7%, and also holds a Zacks Rank of 3 (Hold) [6]

Footwear name Nike Inc (NYSE:NKE) will announce its fiscal fourth-quarter earnings report after the close on Thursday, June 26. Analysts are expecting an earnings per share (EPS) of 11 cents, on revenue of $10.67 billion. Ahead of the event, Raymond James reiterated its "market perform" rating, suggesting results won't be as bad as anticipated, despite tariff concerns. However, it's worth noting that Nike stock has a fairly dismal post-earnings history. The stock finished the session lower following seven o ...

CF Industries (CF) shares ended the last trading session 6.5% higher at $99.93. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 8.8% gain over the past four weeks.CF shares jumped following the Environmental Protection Agency's new proposal to boost biofuel blending mandates, expected to benefit biomass-based diesel production. Being among the largest ammonia producers globally, CF will benefit from this initiative ...

Group 1: Company Performance - United Natural Foods (UNFI) shares increased by 7.6% to close at $30.57, with notable trading volume compared to typical sessions, and a total gain of 17.3% over the past four weeks [1][2] - The stock's rise is driven by optimism regarding its wholesale segment, new business from existing and newly acquired customers, and the impact of inflation, alongside a focus on lean management and operational efficiency [2] - The company is expected to report quarterly earnings of $0.23 per share, reflecting a year-over-year increase of 130%, with revenues projected at $7.82 billion, up 4.2% from the previous year [3] Group 2: Earnings Estimates and Market Position - The consensus EPS estimate for UNFI has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] - UNFI currently holds a Zacks Rank of 3 (Hold), while another company in the same industry, Campbell's (CPB), has a Zacks Rank of 4 (Sell) and reported a 1.9% increase in its last trading session [4][5] - Campbell's EPS estimate for the upcoming report is $0.65, which is a decrease of 13.3% from the previous year [5]

Group 1 - Gossamer Bio reported a quarterly loss of $0.16 per share, better than the Zacks Consensus Estimate of a loss of $0.18, and an improvement from a loss of $0.19 per share a year ago, resulting in an earnings surprise of 11.11% [1] - The company achieved revenues of $9.89 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 167.27%, compared to zero revenues a year ago [2] - Gossamer Bio shares have increased approximately 11.7% since the beginning of the year, outperforming the S&P 500's gain of 0.2% [3] Group 2 - The earnings outlook for Gossamer Bio is mixed, with the current consensus EPS estimate for the upcoming quarter at -$0.18 on revenues of $4.13 million, and -$0.66 on revenues of $26.3 million for the current fiscal year [7] - The Medical - Biomedical and Genetics industry, to which Gossamer Bio belongs, is currently ranked in the top 28% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] Group 3 - Gossamer Bio has surpassed consensus EPS estimates three times over the last four quarters, indicating a positive trend in earnings performance [2] - The estimate revisions trend for Gossamer Bio is currently mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6]